share_log
Hi,
moomoo ID:0
Log Out
English
Back
  • English
  • 中文繁体
  • 中文简体

Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session

Benzinga Real-time News ·  09/29 00:42

Gainers

  • Prothena Corporation plc (NASDAQ:PRTA) shares climbed 76.4% to $54.54 after Biogen and Eisai Co. Ltd. announced late Tuesday positive results from a late-stage study of their Alzheimer's treatment candidate. Prothena is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative diseases, like Alzheimer's.
  • Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) shares gained 72.1% to $8.09 after Biogen and Eisai announced their Phase 3 Clarity study of lecanemab met its primary endpoint.
  • PepGen Inc. (NASDAQ:PEPG) gained 70% to $8.86 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial met its primary endpoint.
  • bioAffinity Technologies, Inc. (NASDAQ:BIAF) gained 63.7% to $3.47 after the company announced it received an additional $7.7 million from the exercise of warrants.
  • BTRS Holdings Inc. (NASDAQ:BTRS) climbed 59.5% to $9.20. The EQT X fund agreed to acquire BTRS Holdings, a B2B accounts receivable automation and integrated payments company, in an all-cash transaction valuing Billtrust's equity at $1.7 billion.
  • Atlis Motor Vehicles Inc (NASDAQ:AMV) rose 54.7% to $127.00 after jumping around 199% on Tuesday.
  • Biogen Inc. (NASDAQ:BIIB) shares rose 35.3% to $267.60. Biogen and Eisai Co. announced late Tuesday positive results from a late-stage study of their Alzheimer's treatment candidate.
  • SOBR Safe, Inc. (NASDAQ:SOBR) gained 29.6% to $1.75 after the company announced its SOBRcheck is replacing breathalyzers in the American judicial system.
  • Top Ships Inc. (NASDAQ:TOPS) climbed 28% to $3.0046 after the company announced 1H FY22 revenue of $38.8 million, which is up 53% year over year.
  • FingerMotion, Inc. (NASDAQ:FNGR) gained 23.3% to $1.32.
  • Quanterix Corporation (NASDAQ:QTRX) rose 22.2% to $9.86.
  • ProMIS Neurosciences, Inc. (NASDAQ:PMN) gained 22.2% to $6.10.
  • MorphoSys AG (NASDAQ:MOR) rose 20% to $5.34.
  • Aspen Group, Inc. (NASDAQ:ASPU) surged 19.7% to $0.3949. Aspen Group Director Douglas Kass acquired a total of 61,500 shares at an average price of $0.42.
  • Denali Therapeutics Inc. (NASDAQ:DNLI) gained 19.6% to $32.65.
  • KLX Energy Services Holdings, Inc. (NASDAQ:KLXE) gained 19.4% to $6.39. KLX Energy Services raised Q3 sequential revenue growth from 9%-13% to 16%-18% and adjusted EBITDA from 10%-12% to 14%-16%.
  • Neuronetics, Inc. (NASDAQ:STIM) gained 19.3% to $2.84.
  • Nano-X Imaging Ltd. (NASDAQ:NNOX) gained 18.3% to $12.03. Nano X Imaging, last month, posted a Q2 loss of $0.16 per share.
  • AC Immune SA (NASDAQ:ACIU) gained 18.2% to $2.98. Shares of companies with Alzheimer's programs traded higher after Biogen and Eisai announced their Phase 3 Clarity study of lecanemab met its primary endpoint.
  • Invitae Corporation (NYSE:NVTA) climbed 18% to $2.7850.
  • RadNet, Inc. (NASDAQ:RDNT) gained 17.7% to $21.13.
  • Mondee Holdings, Inc. (NASDAQ:MOND) rose 17.6% to $10.37.
  • Janux Therapeutics, Inc. (NASDAQ:JANX) jumped 17% to $14.97.
  • Good Times Restaurants Inc. (NASDAQ:GTIM) gained 16.4% to $2.5899.
  • Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) surged 14.5% to $3.30.
  • Janux Therapeutics, Inc. (NASDAQ:JANX) gained 14.3% to $14.62.
  • Coeur Mining, Inc. (NYSE:CDE) jumped 13% to $3.20.
  • Pacific Biosciences of California, Inc. (NASDAQ:PACB) gained 12% to $5.89.
  • Peabody Energy Corporation (NYSE:BTU) surged 10.7% to $24.65.
  • Silo Pharma, Inc. (NASDAQ:SILO) rose 9.4% to $5.53 following uplisting to the Nasdaq.
  • Lilly and Company (NYSE:LLY) rose 8.7% to $338.31. Shares of companies with potential Alzheimer's treatments traded higher in sympathy with Biogen.
  • Yamana Gold Inc. (NYSE:AUY) gained 8.4% to $4.3450.


Losers

  • PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) tumbled 62.8% to $0.2821 after the company announced it received a notice that its partner SFJ Pharmaceuticals Group elected to transfer bentracimab rights to SFJ as PhaseBio failed to remedy its Going Concern Condition.
  • Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) shares dipped 49.3% to $3.1050 after the company priced a 7.05 million share offering of common shares and warrants at $4.25 per share plus warrants.
  • Nano Labs Ltd (NASDAQ:NA) fell 36.8% to $2.01 after the company priced a roughly 2.08 million ADS public offering at $2.40 per ADS.
  • iBio, Inc. (NYSE:IBIO) shares fell 33.5% to $0.2101 after the company reported FY22 preliminary sales results and announced a 1-for-25 reverse stock split.
  • iPower Inc. (NASDAQ:IPW) dropped 23.9% to $0.7798 after the company released its financial results for its fiscal fourth quarter and full year ended June 30, 2022.
  • A2Z Smart Technologies Corp. (NASDAQ:AZ) fell 23% to $1.67.
  • Grove Collaborative Holdings, Inc. (NYSE:GROV) declined 22.2% to $3.12.
  • Vitru Limited (NASDAQ:VTRU) dropped 19.9% to $17.04.
  • Gamida Cell Ltd. (NASDAQ:GMDA) fell 16.8% to $1.6310 after the company priced 12.9 nm share public offering of common stock at $1.55 per share.
  • Allego N.V. (NYSE:ALLG) dipped 15.4% to $4.9750.
  • Loyalty Ventures Inc. (NASDAQ:LYLT) fell 14% to $1.5050.
  • LiveWire Group Inc (NYSE:LVWR) dropped 13% to $7.18.
  • Presto Automation, Inc (NASDAQ:PRST) fell 11.9% to $2.3710. The company recently completed its previously announced business combination with Ventoux CCM Acquisition.
  • XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) fell 11.8% to $1.19.
  • Sonendo, Inc. (NASDAQ:SONX) fell 11.6% to $1.4750.
  • Algoma Steel Group Inc. (NASDAQ:ASTL) dropped 10% to $6.68. Algoma Steel said it sees Q2 adjusted EBITDA of $75 million to $80 million.
  • Novonix Limited (NYSE:NVX) dipped 9.6% to $4.80.
  • Sandstorm Gold Ltd. (NYSE:SAND) fell 9.4% to $5.04 after the company announced an $80 million bought deal financing.
  • Avenue Therapeutics, Inc. (NASDAQ:ATXI) fell 9.3% to $6.57. The stock has been volatile after the company last week announced a 1-for-15 reverse split and received meeting minutes from the FDA regarding a meeting conducted on August 9, 2022, for IV Tramadol.
  • DBV Technologies S.A. (NASDAQ:DBVT) dropped 7% to $1.85.
  • XPeng Inc. (NYSE:XPEV) fell 5.7% to $12.93.

This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors’ financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. Moomoo makes no representation or warranty as to its adequacy, completeness, accuracy or timeliness for any particular purpose of the above content.

Moomoo is a financial information and trading app offered by Moomoo Technologies Inc.
In the U.S., investment products and services available through the moomoo app are offered by Moomoo Financial Inc., a broker-dealer registered with the U.S. Securities and Exchange Commission (SEC) and a member of Financial Industry Regulatory Authority (FINRA)/Securities Investor Protection Corporation (SIPC).
In Singapore, investment products and services available through the moomoo app are offered through Moomoo Financial Singapore Pte. Ltd. regulated by the Monetary Authority of Singapore (MAS). Moomoo Financial Singapore Pte. Ltd. is a Capital Markets Services Licence (License No. CMS101000) holder with the Exempt Financial Adviser Status. This advertisement has not been reviewed by the Monetary Authority of Singapore.
In Australia, financial products and services available through the moomoo app are provided by Futu Securities (Australia) Ltd, an Australian Financial Services Licensee (AFSL No. 224663) regulated by the Australian Securities and Investment Commission (ASIC). Please read and understand our Financial Services Guide, Terms and Conditions, Privacy Policy and other disclosure documents which are available on our websites https://www.futuau.com and https://www.moomoo.com/au. Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd. and Futu Securities (Australia) Ltd are affiliated companies.